Skip to main content

Table 2 FIGO stages of the HGSOC patients

From: Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

 

HGSOC patients

(n = 30)

FIGO Stage

I

5 (17%)

II

3 (10%)

III

21 (70%)

IV

1 (3%)

  1. Abbreviations: FIGO Federation of Gynecology and Obstetrics, HGSOC high grade serous ovarian cancer
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us